{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:19:04Z","timestamp":1761751144547,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jiph.2023.02.008","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T02:12:52Z","timestamp":1676254372000},"page":"673-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of nonalcoholic fatty liver disease on clinical outcomes in patients with COVID-19 among persons living with HIV: A multicenter research network study"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9452-7377","authenticated-orcid":false,"given":"Arunkumar","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinsay A.","family":"Woreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar T.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2023.02.008_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11739-020-02616-5","article-title":"A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations","author":"Krishnan","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jiph.2023.02.008_bib2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically Ill patients with coronavirus disease 2019 in the US","author":"Gupta","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jiph.2023.02.008_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12998\/wjcc.v9.i1.8","article-title":"COVID-19: an overview and a clinical update","author":"Krishnan","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jiph.2023.02.008_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cid\/ciaa863","article-title":"COVID-19 in immunocompromised hosts: what we know so far","author":"Fung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.02.008_bib5","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2352-3018(21)00239-3","article-title":"National COVID Cohort Collaborative Consortium. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data","author":"Yang","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jiph.2023.02.008_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.596631","article-title":"Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System","volume":"11","author":"Peng","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2023.02.008_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","article-title":"Non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia","volume":"112","author":"Nseir","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.jiph.2023.02.008_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43066-021-00084-w","article-title":"The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients","volume":"11","author":"Megahed","year":"2011","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jiph.2023.02.008_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5152\/tjg.2022.21467","article-title":"Helicobacter pylori infection and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"33","author":"Heydari","year":"2022","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jiph.2023.02.008_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.metabol.2019.04.012","article-title":"Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: an updated meta-analysis","volume":"96","author":"Mantovani","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jiph.2023.02.008_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3748\/wjg.v28.i5.570","article-title":"Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients","volume":"28","author":"Krishnan","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiph.2023.02.008_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jiph.2023.02.008_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.24875\/AIDSRev.18000008","article-title":"Non-alcoholic fatty liver disease in patients with HIV infection","volume":"20","author":"Papagianni","year":"2018","journal-title":"AIDS Rev"},{"key":"10.1016\/j.jiph.2023.02.008_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cgh.2020.10.018","article-title":"Expert panel review on nonalcoholic fatty liver disease in persons with human immunodeficiency virus","volume":"20","author":"Lake","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib16","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/QAD.0000000000001241","article-title":"Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients","volume":"30","author":"Vuille-Lessard","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2023.02.008_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MCG.0b013e318264181d","article-title":"Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse","volume":"47","author":"Sterling","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jiph.2023.02.008_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jiph.2023.02.008_bib19","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/cid\/ciaa382","article-title":"Clinical predictors of liver fibrosis presence and progression in human immunodeficiency virus-associated nonalcoholic fatty liver disease","volume":"72","author":"Fourman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2023.02.008_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S2468-1253(16)30120-0","article-title":"Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV","volume":"2","author":"Verna","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40121-018-0229-7","article-title":"A review of non-alcoholic fatty liver disease in HIV-infected patients: the next big thing?","author":"van Welzen","year":"2019","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jiph.2023.02.008_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","author":"Koethe","year":"2016","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.jiph.2023.02.008_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1468-1293.2010.00904.x","article-title":"Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons(*)","volume":"12","author":"Crum-Cianflone","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.jiph.2023.02.008_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/QAI.0000000000002359","article-title":"Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons With HIV","volume":"84","author":"Kaplan","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiph.2023.02.008_bib25","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/MEG.0000000000001902","article-title":"Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study","author":"Mahamid","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MCG.0000000000001605","article-title":"Risk of severe COVID-19 increased by metabolic dysfunction-associated fatty liver disease: a meta-analysis","volume":"55","author":"Tao","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jiph.2023.02.008_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.dsx.2021.03.019","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: a comprehensive systematic review and meta-analysis","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jiph.2023.02.008_bib28","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/hep4.1802","article-title":"Independent predictors of mortality among patients with NAFLD hospitalized with COVID-19 infection","volume":"6","author":"Younossi","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jiph.2023.02.008_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tem.2021.01.001","article-title":"Altered cholesterol and lipid synthesis mediates hyperinflammation in COVID-19","author":"Sohrabi","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jiph.2023.02.008_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cgh.2020.10.018","article-title":"Expert panel review on nonalcoholic fatty liver disease in persons with human immunodeficiency virus","author":"Lake","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.dsx.2020.06.013","article-title":"Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19","author":"Sharma","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jiph.2023.02.008_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8407990","article-title":"Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network","author":"Krishnan","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jiph.2023.02.008_bib34","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/S2352-3018(22)00097-2","article-title":"Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19","volume":"9","author":"Bertagnolio","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jiph.2023.02.008_bib35","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection","volume":"31","author":"Maurice","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2023.02.008_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiph.2023.02.008_bib37","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.jinf.2020.06.036","article-title":"CD4+T, CD8+T counts and severe COVID-19: a meta-analysis","author":"Zhang","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2023.02.008_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jiaa380","article-title":"Clinical outcomes and immunologic characteristics of coronavirus disease 2019 in people with human immunodeficiency virus","volume":"223","author":"Ho","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiph.2023.02.008_bib39","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jmv.25782","article-title":"SARS-CoV-2 and HIV","volume":"92","author":"Joob","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2023.02.008_bib40","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s10461-020-02871-9","article-title":"The Burden of COVID-19 in people living with HIV: a syndemic perspective","volume":"24","author":"Shiau","year":"2020","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jiph.2023.02.008_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","author":"Martinez","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2023.02.008_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/13813455.2020.1745851","article-title":"Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches","volume":"128","author":"Sharma","year":"2022","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.jiph.2023.02.008_bib43","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2023.02.008_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41581-020-0284-7","article-title":"Kidney involvement in COVID-19 and rationale for extracorporeal therapies","volume":"16","author":"Ronco","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jiph.2023.02.008_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jiph.2023.02.008_bib46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiph.2023.02.008_bib47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat Rev Nephrol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034123000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:15:20Z","timestamp":1761750920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034123000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1876034123000394"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2023.02.008","relation":{},"ISSN":["1876-0341"],"issn-type":[{"type":"print","value":"1876-0341"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of nonalcoholic fatty liver disease on clinical outcomes in patients with COVID-19 among persons living with HIV: A multicenter research network study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2023.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}